Wei Eric Wang | Myocardial Infarction | Best Researcher Award

Posted on by Pencis

Prof. Wei Eric Wang | Myocardial Infarction | Best Researcher Award

Prof. Wei Eric Wang, Southwest Hospital, Army Medical University, China

Prof. Wei Eric Wang is a distinguished medical professional based at Southwest Hospital, Army Medical University, in China. Renowned for his expertise in medical research and clinical practice, he has contributed significantly to the fields of surgery, healthcare management, and medical education. With numerous publications in peer-reviewed journals, Prof. Wang has established a reputation for pioneering studies in his area of specialization. He is also actively involved in advancing medical training, and his leadership at the hospital continues to shape healthcare innovation in China. His work has earned him recognition both nationally and internationally.

AUTHOR PROFILE

Scopus

Orcid

🎓EARLY ACADEMIC PURSUITS:

Dr. Wei (Eric) Wang pursued his medical education at the Third Military Medical University in Chongqing, China. He earned his M.D. in Clinical Medicine from 2000 to 2005. Following this, he completed his Ph.D. at the Institute of Burn Surgery, Southwest Hospital, at the same university between 2005 and 2010. His early academic endeavors laid the foundation for his expertise in cardiology and geriatric medicine.

🏥PROFESSIONAL ENDEAVORS:

Dr. Wang has held various prestigious positions throughout his career. He has been the Director of the Department of Geriatrics at Southwest Hospital since November 2022, demonstrating his leadership in the field. Prior to this, he served as Chief Physician and Professor in the Department of Cardiology at Daping Hospital, Army Medical University. His extensive experience includes roles such as Deputy Director, Associate Chief Physician, Attending Doctor, and Resident, reflecting his progressive career growth and expertise in cardiology and geriatrics.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON Myocardial Infarction

Dr. Wang’s research is centered on new strategies for treating cardiovascular diseases, particularly myocardial infarction and heart failure. His primary areas of focus include:

  1. Mechanisms regulating cardiac regeneration.
  2. Translational and clinical studies for treating cardiovascular diseases.
  3. Translational and clinical research for preventing aging.

His work has significantly advanced the understanding of cardiac repair mechanisms and potential therapeutic interventions.

🌍IMPACT AND INFLUENCE:

Dr. Wang has played a crucial role in the field of cardiology and geriatrics. His research has contributed to innovative treatments that enhance cardiac regeneration and improve patient outcomes. As a leader in cardiovascular medicine, his influence extends beyond clinical practice to shaping future medical research and treatment methodologies.

📚ACADEMIC CITATIONS AND RECOGNITION:

Dr. Wang has an impressive list of publications in esteemed medical journals. Some of his notable works include:

  1. “Metabolic reprogramming: a byproduct or a driver of cardiomyocyte proliferation?” published in Circulation (2024).
  2. “Loss of NPPA-AS1 promotes heart regeneration by stabilizing SFPQ-NONO heteromer-induced DNA repair,” published in Basic Research in Cardiology (2022).
  3. “The Role of G Protein-Coupled Receptor Kinase 4 in Cardiomyocyte Injury after Myocardial Infarction,” published in European Heart Journal (2021).
  4. “Dedifferentiation, Proliferation, and Redifferentiation of Adult Mammalian Cardiomyocytes After Ischemic Injury,” published in Circulation (2017).

These publications highlight his extensive contributions to cardiovascular research and his role in advancing medical knowledge in this domain.

🌟LEGACY AND FUTURE CONTRIBUTIONS:

Dr. Wang’s legacy is deeply rooted in his contributions to cardiovascular research, innovative treatment strategies, and leadership in geriatric medicine. As a distinguished professor and researcher, his work continues to shape the future of cardiology and geriatrics. His ongoing research and clinical innovations are expected to provide new breakthroughs in cardiac care and aging prevention, benefiting future generations of patients and medical professionals.

🚀CONCLUSION:

Prof. Wei Eric Wang is a distinguished cardiologist and geriatrician whose groundbreaking research and leadership have significantly impacted cardiovascular medicine. His dedication to innovation, patient care, and scientific discovery continues to inspire future generations. As Director of Geriatrics at Southwest Hospital, his work advances both clinical and translational medicine, improving lives worldwide. With numerous influential publications and a commitment to pioneering treatments, his contributions to cardiac regeneration and aging prevention are invaluable. His legacy in medicine and academia ensures a lasting impact, shaping the future of healthcare and research.

TOP NOTABLE PUBLICATIONS

  • Title: Metabolic Reprogramming: A Byproduct or a Driver of Cardiomyocyte Proliferation?
    Authors: Xiaokang Chen, Hao Wu, Ya Liu, Lingyan Liu, Steven R. Houser, Wei Eric Wang
    Journal: Circulation
    Year: 2024

  • Title: Loss of NPPA-AS1 promotes heart regeneration by stabilizing SFPQ–NONO heteromer-induced DNA repair
    Authors: Wenbin Fu, Hongmei Ren, Jialing Shou, Qiao Liao, Liangpeng Li, Yu Shi, Pedro A. Jose, Chunyu Zeng, Wei Eric Wang
    Journal: Basic Research in Cardiology
    Year: 2022

  • Title: The Protective Role of Yin‐Yang 1 in Cardiac Injury and Remodeling After Myocardial Infarction
    Authors: Yu Huang, Liangpeng Li, Hongmei Chen, Qiao Liao, Xiaoli Yang, Dezhong Yang, Xuewei Xia, Hongyong Wang, Wei Eric Wang, Lianglong Chen et al.
    Journal: Journal of the American Heart Association
    Year: 2021

  • Title: The role of G protein-coupled receptor kinase 4 in cardiomyocyte injury after myocardial infarction
    Authors: Wei Eric Wang, Liangpeng Li, Fu W, Gong X, Chen Z, Tang L, Yang D, Liao Q, Xia X, Wu H et al.
    Journal: European Heart Journal
    Year: 2021

  • Title: An Aurora Kinase B-Based Mouse System to Efficiently Identify and Analyze Proliferating Cardiomyocytes
    Authors: Wei Eric Wang, Fu W, Liao Q, Li L, Shi Y, Zeng A, Zeng C, Wang WE
    Journal: Frontiers in Cell and Developmental Biology
    Year: 2020

  • Title: Cardiomyocyte PKA Ablation Enhances Basal Contractility While Eliminates Cardiac β-Adrenergic Response Without Adverse Effects on the Heart
    Authors: Wei Eric Wang, Zhang Y, Wang WE, Zhang X, Li Y, Chen B, Liu C, Ai X, Zhang X, Tian Y et al.
    Journal: Circulation Research
    Year: 2019

  • Title: Noncoding RNA and Cardiomyocyte Proliferation
    Authors: Shuang Qu, Chunyu Zeng, Wei Eric Wang
    Journal: Stem Cells International
    Year: 2017

  • Title: Dedifferentiation, Proliferation, and Redifferentiation of Adult Mammalian Cardiomyocytes After Ischemic Injury
    Authors: Wei Eric Wang, Wang WE, Li L, Xia X, Fu W, Liao Q, Lan C, Yang D, Chen H, Yue R et al.
    Journal: Circulation
    Year: 2017

  • Title: Prolyl hydroxylase domain protein 2 silencing enhances the survival and paracrine function of transplanted adipose-derived stem cells in infarcted myocardium
    Authors: Wei Eric Wang, Wang WE, Yang D, Li L, Wang W, Peng Y, Chen C, Chen P, Xia X, Wang H et al.
    Journal: Circulation Research
    Year: 2013

Ming-Yow Hung | Interventional Cardiology | Best Researcher Award

Posted on by Pencis

Prof. Ming-Yow Hung | Interventional Cardiology | Best Researcher Award

Yingqiang Du | Myocardial Infarction | Best Researcher Award

Posted on by Pencis

Dr. Yingqiang Du | Myocardial Infarction | Best Researcher Award

Dr. Yingqiang Du, Department of Cardiology, The Affiliated Suzhou Hospital of Nanjing Medical University; Suzhou Municipal Hospital; Gusu School, Nanjing Medical University, China

Dr. Yingqiang Du is a renowned cardiology researcher at The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, and Gusu School, Nanjing Medical University, China. His research focuses on myocardial infarction and ischemic heart disease, exploring inflammation, fibrosis, metabolic remodeling, and novel therapeutic strategies. As the first or corresponding author of multiple high-impact publications, he has significantly contributed to cardiovascular medicine. His work bridges basic and clinical research, influencing treatment advancements and patient care. With ongoing projects funded by prestigious grants, Dr. Du continues to drive innovation in cardiology, shaping the future of cardiovascular health research.

AUTHOR PROFILE

Scopus Profile

Orcid Profile

📚 EARLY ACADEMIC PURSUITS:

Dr. Yingqiang Du began his academic journey with a strong foundation in medical sciences, focusing on cardiology and cardiovascular research. His early education provided him with a deep understanding of human physiology, pathology, and the complexities of ischemic heart disease. With a keen interest in myocardial infarction and its underlying mechanisms, he pursued specialized training and research, laying the groundwork for his future contributions to the field.

🏥 PROFESSIONAL ENDEAVORS:

Currently, Dr. Du is affiliated with The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, and Gusu School, Nanjing Medical University. As a researcher and academic professional, he has taken on significant responsibilities in both clinical and experimental cardiology. His work bridges the gap between theoretical research and practical applications, ensuring that scientific findings translate into improved patient care.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON MYOCARDIAL INFARCTION:

Dr. Du’s research primarily centers on myocardial infarction and ischemic heart disease. His studies delve into various aspects, including:

  • The role of inflammation and fibrosis in cardiovascular conditions.
  • The impact of environmental factors, such as micro(nano)plastics, on heart disease.
  • Novel therapeutic approaches involving bioactive compounds like resveratrol and muscone.
  • The involvement of metabolic remodeling and inflammasome activation in aging cells. His extensive work provides crucial insights into the prevention, diagnosis, and treatment of cardiac disorders.

🌟 IMPACT AND INFLUENCE:

Dr. Du’s research has had a profound impact on the field of cardiology. His studies have contributed to a better understanding of the molecular mechanisms of myocardial infarction and fibrosis, paving the way for new treatment modalities. His findings have influenced clinical practices and have been referenced in various medical and scientific discussions worldwide.

📖 ACADEMIC CITES:

As an established researcher, Dr. Du has authored multiple high-impact publications in reputed journals, including:

  • Journal of Hazardous Materials
  • Clinical and Translational Medicine
  • Experimental and Therapeutic Medicine
  • Bioengineered
  • American Journal of Translational Research These publications, where he serves as either the first or corresponding author, reflect his credibility and expertise in the field. His work has been widely cited by peers, demonstrating its relevance and significance.

🏆 LEGACY AND FUTURE CONTRIBUTIONS:

Dr. Du’s contributions to cardiology are paving the way for future breakthroughs in cardiovascular medicine. His research findings are not only enhancing current medical knowledge but also inspiring upcoming researchers to explore novel therapeutic strategies. Moving forward, his work is expected to contribute significantly to:

  • The development of innovative drug treatments for myocardial infarction.
  • The formulation of preventive measures against ischemic heart disease.
  • The exploration of new molecular pathways for better cardiovascular health. His ongoing commitment to research excellence ensures that his legacy will continue to shape the future of cardiology.

🌍CONCLUSION:

Dr. Yingqiang Du is a distinguished researcher whose groundbreaking contributions to cardiology have significantly advanced the understanding of myocardial infarction and ischemic heart disease. His extensive studies on inflammation, fibrosis, and metabolic remodeling have influenced both clinical practices and future research directions. With multiple high-impact publications and ongoing projects, his work continues to shape modern cardiovascular medicine.

TOP NOTABLE PUBLICATION

Title:  Exposure to polyethylene terephthalate micro(nano)plastics exacerbates inflammation and fibrosis after myocardial infarction by reprogramming the gut and lung microbiota and metabolome

Authors: X., Gu, Xin, Z., Zhang, Zhixuan, L., Zhao, Lin, … X., Wang, Xiaoyan, Y., Du, Yingqiang

Journal:  Journal of Hazardous Materials

Year: 2025

Fulin Liu | Cardiology | Best Researcher Award

Posted on by Pencis

Prof. Fulin Liu | Cardiology | Best Researcher Award

Prof. Fulin Liu, Affiliated Hospital of Hebei University , China

Prof. Fulin Liu is a distinguished researcher and cardiac surgeon affiliated with the Affiliated Hospital of Hebei University, where he has worked since 1988. He holds a degree from Hebei Medical University and has made significant contributions to cardiovascular health, particularly in myocardial ischemia-reperfusion injury and the therapeutic effects of hydrogen-rich water. Liu has authored numerous high-impact journal articles, with recent work focusing on mitochondrial function, glioma research, and innovative healthcare solutions. His research is widely recognized in leading medical journals, underscoring his global impact and ongoing commitment to advancing medical science and patient care.

Author Profile:

🎓 Education:

Prof. Fulin Liu completed his undergraduate education at Hebei Medical University in Shijiazhuang City, Hebei, China. He attended the university from September 1983 to June 1988, where he received a medical degree, which laid the foundation for his career in cardiac surgery and medical research. This academic background has been pivotal in shaping his research focus, particularly in the fields of cardiovascular health, ischemia-reperfusion injury, and the application of hydrogen-rich water in medical treatments. Liu’s educational experiences at Hebei Medical University have significantly influenced his innovative contributions to healthcare and medical science.

💼 Professional Experience:

Prof. Fulin Liu has extensive professional experience in both clinical and research settings. Since 1988, he has been a cardiac surgeon at the Affiliated Hospital of Hebei University, where he has developed expertise in treating cardiovascular conditions, particularly myocardial ischemia-reperfusion injury. In addition to his clinical role, Liu has made significant contributions to medical research, publishing numerous articles on topics such as hydrogen-rich water, mitochondrial function, and glioma. His work bridges the gap between clinical practice and scientific discovery, advancing both patient care and medical knowledge. Liu’s career reflects a dedicated commitment to improving cardiovascular health and innovative therapies.

🌍Research Contributions:

Prof. Fulin Liu’s research contributions focus primarily on cardiovascular health, particularly myocardial ischemia-reperfusion injury and the protective effects of hydrogen-rich water. His studies have revealed critical insights into mitochondrial function and its role in heart disease, with a focus on improving therapeutic strategies. Liu has also made notable contributions to the understanding of gliomas, including the role of circular RNAs and N6-methyladenosine modifications in tumor progression. His work extends to advanced healthcare technologies, such as knowledge graphs and mobile computing in medical applications. Through his numerous published articles, Liu continues to drive innovative research with significant clinical and therapeutic implications.

🥇Award and Honors:

Prof. Fulin Liu has received numerous awards and honors throughout his distinguished career, recognizing his contributions to the field of cardiac surgery and medical research. His groundbreaking work on myocardial ischemia-reperfusion injury, hydrogen-rich water’s therapeutic effects, and his studies on gliomas have earned him widespread acclaim in the scientific community. Liu’s research has been published in top-tier medical journals, and his expertise has garnered international recognition. His dedication to advancing both clinical practices and scientific understanding has established him as a leader in his field, earning him significant accolades and reinforcing his reputation as a pioneering researcher.

Conclusion:

Prof. Fulin Liu’s extensive research and clinical expertise have made him a prominent figure in the field of cardiac surgery and biomedical research. His work on myocardial ischemia-reperfusion injury, hydrogen-rich water, and its therapeutic potential highlights his commitment to advancing cardiovascular medicine. Liu’s contributions to the understanding of molecular mechanisms in diseases like glioma further underscore his multidisciplinary approach to health research. With a remarkable publication record and ongoing involvement in clinical practice, Liu’s impact on both academic and medical communities is profound, establishing him as a leading figure in his field.

📚Publication Top Notes:

Hydrogen Protects Mitochondrial Function by Increasing the Expression of PGC-1α and Ameliorating Myocardial Ischaemia–Reperfusion Injury
Journal of Cellular and Molecular Medicine, 2024
📖 Citations: 0
[DOI: 10.1111/jcmm.70236]

Spatiotemporal lipidomics reveals key features of brain lipid dynamic changes after cerebral ischemia and reperfusion therapy
Pharmacological Research, 2022
🧠 Citations: 15
[DOI: 10.1016/j.phrs.2022.106482]

Identification and characterization of N6-methyladenosine modification of circRNAs in glioblastoma
Journal of Cellular and Molecular Medicine, 2021
🔬 Citations: 8
[DOI: 10.1111/jcmm.16750]

Multitask Healthcare Management Recommendation System Leveraging Knowledge Graph
Journal of Healthcare Engineering, 2021
💡 Citations: 19
[DOI: 10.1155/2021/1233483]

Medical Knowledge Graph in Chinese Using Deep Semantic Mobile Computation Based on IoT and WoT
Wireless Communications and Mobile Computing, 2021
🌐 Citations: 6
[DOI: 10.1155/2021/5590754]

M6A modification in RNA: Biogenesis, functions and roles in gliomas
Journal of Experimental and Clinical Cancer Research, 2020
🧬 Citations: 117
[DOI: 10.1186/s13046-020-01706-8]

Metabolomics Analysis of the Effect of Hydrogen-Rich Water on Myocardial Ischemia-Reperfusion Injury in Rats
Journal of Bioenergetics and Biomembranes, 2020
💧 Citations: 6
[DOI: 10.1007/s10863-020-09835-7]

Advances in circular RNAs and their role in glioma (Review)
International Journal of Oncology, 2020
🔄 Citations: 26
[DOI: 10.3892/ijo.2020.5049]

New understanding of the damage of SARS-CoV-2 infection outside the respiratory system
Biomedicine and Pharmacotherapy, 2020
🦠 Citations: 222
[DOI: 10.1016/j.biopha.2020.110195]

Pressurizing and Stretching Experiment in Arterialized Veins of Rabbits
Yiyong Shengwu Lixue/Journal of Medical Biomechanics, 2020
🐇 Citations: Not available
[DOI: 10.3969/j.issn.1005-8936.2020.02.006]